Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
baricitinib tyrosine-protein kinase jak1 small molecule NA drugbank , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
1.33 approved,investigational inhibitor
baricitinib janus kinase 1 NA Successful target TTD , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
1.33 approved inhibitor
baricitinib tyrosine-protein kinase jak1 small molecule NA drugbank , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]
1.33 approved,investigational inhibitor
baricitinib janus kinase 1 NA Successful target TTD , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
1.33 approved unknown
baricitinib janus kinase 1 NA Successful target TTD , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]
1.33 approved inhibitor
baricitinib janus kinase 1 NA Successful target TTD , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]
1.33 approved unknown
baricitinib tyrosine-protein kinase jak2 small molecule NA drugbank , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]
0.54 approved,investigational inhibitor
baricitinib tyrosine-protein kinase jak2 small molecule NA drugbank , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.54 approved,investigational inhibitor
baricitinib janus kinase 2 NA Successful target TTD , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.54 approved unknown
baricitinib janus kinase 2 NA Successful target TTD , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]
0.54 approved inhibitor
baricitinib janus kinase 2 NA Successful target TTD , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]
0.54 approved unknown
baricitinib janus kinase 2 NA Successful target TTD , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.54 approved inhibitor
baricitinib tyrosine-protein kinase jak3 small molecule NA drugbank , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.15 approved,investigational inhibitor
baricitinib tyrosine-protein kinase jak3 small molecule NA drugbank , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]
0.15 approved,investigational inhibitor
baricitinib protein-tyrosine kinase 2-beta small molecule NA drugbank , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.42 approved,investigational inhibitor
baricitinib protein-tyrosine kinase 2-beta small molecule NA drugbank , DGIDB Rheumatoid Arthritis[MeSHID:D001172]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]
0.42 approved,investigational inhibitor
click here to return to the previous page